Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors (GIST)

Explore clinical trials studying Gastrointestinal Stromal Tumors (GIST). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors (GIST) trial results

Completed

(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

NCT02508532

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +8 more
Locations
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Cancer Treatment Centers of America Atlanta, Georgia, United States
View all 19 locations
View Trial Details
Completed

Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor

NCT00633295

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • Novartis Investigative Site Jerusalem, Israel
  • Novartis Investigative Site Tel Aviv, Israel
  • Novartis Investigative Site Tel Litwinsky, Israel
View Trial Details

Related conditions